Form 4: Onconetix Chief Strategy Officer Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Christian Bruhlmann, Chief Strategy Officer of Onconetix, Inc., reports acquiring and disposing of common stock on December 20, 2024.
Summary
- On December 20, 2024, Christian Bruhlmann, the Chief Strategy Officer of Onconetix, Inc., engaged in transactions involving the company's common stock.
- Bruhlmann acquired 177,462 shares of common stock.
- Bruhlmann disposed of 611,372 shares of common stock.
- Following these transactions, Bruhlmann beneficially owns 611,372 shares of Onconetix common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company insider, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a key company officer.
Key Dates
| Date | Description |
|---|---|
| 12/20/2024 | Date of transaction involving acquisition and disposal of common stock. |
| 01/22/2025 | Date of signature for the report. |
Keywords
Form 4, Onconetix, Bruhlmann, Common Stock, Beneficial Ownership, Officer Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.